{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:43:30Z","timestamp":1774352610611,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.endinu.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,3,18]],"date-time":"2019-03-18T19:07:17Z","timestamp":1552936037000},"page":"402-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome"],"prefix":"10.1016","volume":"66","author":[{"given":"R\u0131fat","family":"Emral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9806-3891","authenticated-orcid":false,"given":"Berna \u0130mge","family":"Aydo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayla Demir","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zg\u00fcr","family":"Demir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demet","family":"\u00c7orap\u00e7\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2019.01.007_bib0170","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2019.01.007_bib0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0889-8529(05)70122-5","article-title":"Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota","volume":"29","author":"Young","year":"2000","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.endinu.2019.01.007_bib0180","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/07435809609043773","article-title":"Adrenal incidentalomas: a manifestation of the metabolic syndrome?","volume":"22","author":"Reincke","year":"1996","journal-title":"Endocr Res"},{"key":"10.1016\/j.endinu.2019.01.007_bib0185","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jcem.87.3.8277","article-title":"Adrenal incidentaloma: a new cause of the metabolic syndrome?","volume":"87","author":"Terzolo","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2019.01.007_bib0190","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2265.1998.00437.x","article-title":"Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma","volume":"49","author":"Fernandez-Real","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endinu.2019.01.007_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.HYP.0000110061.06674.ca","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials","volume":"43","author":"Jones","year":"2004","journal-title":"Hypertension"},{"issue":"Suppl. 2","key":"10.1016\/j.endinu.2019.01.007_bib0200","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults \u2013 the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.endinu.2019.01.007_bib0205","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.endinu.2019.01.007_bib0210","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.endinu.2019.01.007_bib0215","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1046\/j.1365-2265.2001.01274.x","article-title":"The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection","volume":"54","author":"Midorikawa","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endinu.2019.01.007_bib0220","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.metabol.2012.12.006","article-title":"Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications","volume":"62","author":"Ivovic","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.endinu.2019.01.007_bib0225","first-page":"5301","article-title":"Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome","volume":"86","author":"Garrapa","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2019.01.007_bib0230","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/cen.13294","article-title":"Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up","volume":"86","author":"Papanastasiou","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.endinu.2019.01.007_bib0235","doi-asserted-by":"crossref","first-page":"e77326","DOI":"10.1371\/journal.pone.0077326","article-title":"Adequately adapted insulin secretion and decreased hepatic insulin extraction cause elevated insulin concentrations in insulin resistant non-diabetic adrenal incidentaloma patients","volume":"8","author":"Anderwald","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.endinu.2019.01.007_bib0240","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1530\/EJE-14-0345","article-title":"Nonconformity in the clinical practice guidelines for subclinical Cushing's syndrome: which guidelines are trustworthy?","volume":"171","author":"Shen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2019.01.007_bib0245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1507\/endocrj.EJ17-0456","article-title":"New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society","volume":"65","author":"Yanase","year":"2018","journal-title":"Endocr J"},{"key":"10.1016\/j.endinu.2019.01.007_bib0250","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2019.01.007_bib0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP.10.4.353","article-title":"American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines","volume":"10","author":"Mechanick","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1016\/j.endinu.2019.01.007_bib0260","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","article-title":"Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus","volume":"69","author":"Tabarin","year":"2008","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.endinu.2019.01.007_bib0265","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/jama.1986.03380200073024","article-title":"Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study","volume":"256","author":"Castelli","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/j.endinu.2019.01.007_bib0270","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(77)92274-7","article-title":"The Tromso heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study","volume":"1","author":"Miller","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.endinu.2019.01.007_bib0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.85.1.37","article-title":"Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment","volume":"85","author":"Manninen","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.endinu.2019.01.007_bib0280","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1001\/archinte.161.22.2685","article-title":"Total cholesterol\/HDL cholesterol ratio vs LDL cholesterol\/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study","volume":"161","author":"Lemieux","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.endinu.2019.01.007_bib0285","doi-asserted-by":"crossref","first-page":"991","DOI":"10.12659\/MSM.897714","article-title":"Carotid intima-media thickness as the cardiometabolic risk indicator in patients with nonfunctional adrenal mass and metabolic syndrome screening","volume":"22","author":"Evran","year":"2016","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.endinu.2019.01.007_bib0290","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00268-009-0178-0","article-title":"Cardiovascular risk in patients with nonfunctional adrenal incidentaloma: myth or reality?","volume":"33","author":"Erbil","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.endinu.2019.01.007_bib0295","doi-asserted-by":"crossref","first-page":"e37635","DOI":"10.5812\/ijem.37635","article-title":"The relationship between increased epicardial fat thickness and left ventricular hypertrophy and carotid intima-media thickness in patients with nonfunctional adrenal incidentaloma","volume":"14","author":"Imga","year":"2016","journal-title":"Int J Endocrinol Metab"},{"key":"10.1016\/j.endinu.2019.01.007_bib0300","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40618-014-0106-5","article-title":"Non-functioning adrenal incidentalomas are associated with higher hypertension prevalence and higher risk of atherosclerosis","volume":"37","author":"Tuna","year":"2014","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.endinu.2019.01.007_bib0305","first-page":"57","article-title":"Markers of subclinical cardiovascular disease in nonfunctional adrenal incidentaloma patients without traditional cardiovascular risk factors","volume":"125","author":"Cansu","year":"2017","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.endinu.2019.01.007_bib0310","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12020-009-9160-8","article-title":"Carotid intima media thickness is increased and associated with morning cortisol in subjects with non-functioning adrenal incidentaloma","volume":"35","author":"Yener","year":"2009","journal-title":"Endocrine"},{"key":"10.1016\/j.endinu.2019.01.007_bib0315","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/EJE-10-0583","article-title":"Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery","volume":"163","author":"Manetti","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2019.01.007_bib0320","doi-asserted-by":"crossref","first-page":"856","DOI":"10.2174\/138955710791608325","article-title":"The role of the novel adipocyte-derived protein adiponectin in human disease: an update","volume":"10","author":"Diez","year":"2010","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.endinu.2019.01.007_bib0325","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.endinu.2019.01.007_bib0330","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.metabol.2006.12.018","article-title":"Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma","volume":"56","author":"Ermetici","year":"2007","journal-title":"Metabolism"}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016419300370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016419300370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T11:11:03Z","timestamp":1568459463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016419300370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2530016419300370"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2019.01.007","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}